Document Detail

Loss of AChE- and NGFr-labeling precedes neuronal death of axotomized septal-diagonal band neurons: reversal by intraventricular NGF infusion.
MedLine Citation:
PMID:  1868909     Owner:  NLM     Status:  MEDLINE    
The time course of cellular changes in the medial septum (MS) and vertical limb of the diagonal band area (VDB) after a complete unilateral fimbria-fornix (FF) transection has been studied using prelabeling of the septohippocampal neurons by bilateral hippocampal injections of the fluorescent retrograde tracer Fluoro-Gold (FG), in combination with acetylcholine esterase (AChE) histochemistry and nerve growth factor receptor (NGFr) immunocytochemistry. The results show that the long-term disappearance of AChE-positive and NGFr-positive cells represents a combination of down-regulation of the marker proteins, cell shrinkage, and an actual cell loss. By 4 weeks after lesion the loss of FG-prelabeled cells amounted to 50% in MS and 30% in VDB. A further 25-30% of the MS neurons survived (as indicated by the presence of FG label), but were undetectable by the AChE and NGFr markers. Down-regulation of the marker proteins and cell shrinkage preceded the cell loss by more than a week: while shrinkage and reduced numbers of AChE/NGFr positive cells was evident already by 4-7 days, an actual cell loss (i.e., loss of FG-prelabeled cells) became evident only at 4 weeks after lesion. Continuous intraventricular NGF infusion (0.15 micrograms/day) was capable of counteracting all three types of changes. Infusion over 2 weeks reversed both atrophy and loss of AChE/NGFr staining, whereas infusion over 4 weeks completely prevented the later occurring cell loss. In addition, the NGF infusions induced significant hypertrophy in the undamaged cholinergic neurons in both nucleus basalis and striatum. It is concluded that down-regulation of marker proteins, such as AChE and NGFr, and cellular atrophy precede cell death in the axotomized septohippocampal system and that about 1/3 of the axotomized septal cholinergic neurons may survive for a long time in a down-regulated atrophic state. Exogenous NGF can prevent both the atrophic and the degenerative processes.
W Fischer; A Björklund
Related Documents :
1964629 - Alterations in dynamics of microtubule assembly during axonal neuritogenesis in nb2a/d1...
9742929 - Biosynthesis of d-aspartate in mammalian cells.
20434449 - Protein deacetylase sirt1 in the cytoplasm promotes nerve growth factor-induced neurite...
8968029 - Effects of 1alpha,25-dihydroxy-16ene, 23yne-vitamin d3 on osteoblastic function in huma...
12213679 - Nerve growth factor induces the re-expression of functional androgen receptors and p75(...
11129979 - New structural analogues of tubulozole induce apoptosis, [ca2+]i modifications and cyto...
11143399 - Exposure of transformed and non-transformed phagocytic cells to novel glass ionomers in...
19901009 - Living-cell imaging of transgenic rat anterior pituitary cells in primary culture revea...
23893239 - Dual role of sphingosine kinase-1 in promoting the differentiation of dermal fibroblast...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Experimental neurology     Volume:  113     ISSN:  0014-4886     ISO Abbreviation:  Exp. Neurol.     Publication Date:  1991 Aug 
Date Detail:
Created Date:  1991-09-13     Completed Date:  1991-09-13     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0370712     Medline TA:  Exp Neurol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  93-108     Citation Subset:  IM    
Department of Medical Cell Research, University of Lund, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acetylcholinesterase / metabolism*
Axons / physiology*
Cell Survival
Fluorescent Dyes / diagnostic use
Frontal Lobe / cytology*,  metabolism
Injections, Intraventricular
Nerve Growth Factors / metabolism*,  pharmacology
Neurons / metabolism,  physiology*
Septum Pellucidum / cytology*,  metabolism
Time Factors
Grant Support
N506701//PHS HHS
Reg. No./Substance:
0/2-hydroxy-4,4'-diamidinostilbene, methanesulfonate salt; 0/Fluorescent Dyes; 0/Nerve Growth Factors; 0/Stilbamidines; EC

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of applied currents on epileptiform bursts in vitro.
Next Document:  Congenital haemolytic anaemia in a low birth weight infant due to congenital stomatocytosis.